Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
44.68
-0.75 (-1.65%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $348.85 million as of September 18, 2025. Its market cap has increased by 4,889.33% in one year.
Market Cap
348.85M
Enterprise Value
311.59M
1-Year Change
4,889.33%
Ranking
Category
Stock Price
$44.68
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $348.85M, an increase of 734.90%. That is a compound annual growth rate of 58.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 348.85M | 39.18% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | 41.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |